17:32 EST Aptose Biosciences (APTO) files to sell 12.03M shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APTO:
- Aptose Biosciences Establishes $25M Equity Facility
- Promising Results from Aptose Biosciences’ TUSCANY Trial Boost Joseph Pantginis’ Buy Rating
- Promising Early Results from Aptose’s TUSCANY Trial in AML Treatment
- Aptose reports ‘promising’ early safety data from Phase 1/2 TUSCANY trial
- Aptose Biosciences Initiates TUSCANY Trial for Frontline AML Therapy